Erschienen in:
01.06.2011 | Erratum
Erratum to: Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients
verfasst von:
Carlo Buonerba, Piera Federico, Carmine D’Aniello, Pasquale Rescigno, Carla Cavaliere, Livio Puglia, Matteo Ferro, Vincenzo Altieri, Sisto Perdonà, Sabino De Placido, Giuseppe Di Lorenzo
Erschienen in:
Cancer Chemotherapy and Pharmacology
|
Ausgabe 6/2011
Einloggen, um Zugang zu erhalten
Excerpt
We regret the error in corresponding author’s family name in the affiliation section of online published article. The correct family name is Di Lorenzo. …